SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for ...

The new drug application resubmission of rivoceranib/camrelizumab in the first line in unresectable or metastatic ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit ...

According to a preclinical study conducted by Weill Cornell Medicine researchers, it may soon be feasible to detect whether ...

2.1 上海诊疗肝癌流行病学趋势变化（2016—2021年） 2016—2021年，上海市级医院共收治肝癌病人98 960例，其中首次手术病人42 ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell ...

From “Boy Meets World” actress Danielle Fishel discussing her breast cancer surgery to a young TikTok star dying from a rare ...

TikTok star Rachel Yaffe of Maryland died aged 27 on October 11, after seven long years of battling a rare form of liver cancer — fibrolamellar hepatocellular carcinoma. Yaffe, diagnosed at 20 ...

Highlights:,Tempest Therapeutics has entered into an agreement with Roche to advance amezalpat (TPST-1120) in combination ...

Under the agreement, Roche will supply atezolizumab globally and Tempest will sponsor and lead the pivotal study. This agreement builds on a clinical collaboration between the companies pursuant to ...

A court ruled in favor of Exelixis in the oncology company's patent-infringement lawsuit against MSN Laboratories.